Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Carrington Website

Mary N. Carrington, Ph.D.

Selected Publications

1)  Chiu C, McCausland M, Sidney J, Duh FM, Rouphael N, Mehta A, Mulligan M, Carrington M, Wieland A, Sullivan NL, Weinberg A, Levin MJ, Pulendran B, Peters B, Sette A, Ahmed R.
Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV.
PLoS Pathog. 10: e1004008, 2014.
[Journal]
2)  Rizvi SM, Salam N, Geng J, Qi Y, Bream JH, Duggal P, Hussain SK, Martinson J, Wolinsky SM, Carrington M, Raghavan M.
Distinct assembly profiles of HLA-B molecules.
J. Immunol. 192: 4967-76, 2014.
[Journal]
3)  Bashirova AA, Apps R, Vince N, Mochalova Y, Yu XG, Carrington M.
Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair.
Immunogenetics. 66: 1-8, 2014.
[Journal]
4)  Cotton LA, Kuang XT, Le AQ, Carlson JM, Chan B, Chopera DR, Brumme CJ, Markle TJ, Martin E, Shahid A, Anmole G, Mwimanzi P, Nassab P, Penney KA, Rahman MA, Milloy MJ, Schechter MT, Markowitz M, Carrington M, Walker BD, Wagner T, Buchbinder S, Fuchs J, Koblin B, Mayer KH, Harrigan PR, Brockman MA, Poon AF, Brumme ZL.
Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic.
PLoS Genet. 10: e1004295, 2014.
[Journal]
5)  Vince N, Bashirova AA, Lied A, Gao X, Dorrell L, McLaren PJ, Fellay J, Carrington M.
HLA class I and KIR genes do not protect against HIV-1 infection in highly exposed uninfected individuals with hemophilia A.
J. Infect. Dis. [Epub ahead of print], 2014.
[Journal]
6)  Safaeian M, Johnson LG, Yu K, Wang SS, Gravitt PE, Hansen JA, Carrington M, Schwartz SM, Gao X, Hildesheim A, Madeleine MM.
Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma.
Front Oncol. 4: 119, 2014.
[Journal]
7)  Bashirova AA, Martin-Gayo E, Jones DC, Qi Y, Apps R, Gao X, Burke PS, Taylor CJ, Rogich J, Wolinsky S, Bream JH, Duggal P, Hussain S, Martinson J, Weintrob A, Kirk GD, Fellay J, Buchbinder SP, Goedert JJ, Deeks SG, Pereyra F, Trowsdale J, Lichterfeld M, Telenti A, Walker BD, Allen RL, Carrington M, Yu XG.
LILRB2 interaction with HLA class I correlates with control of HIV-1 infection.
PLoS Genet. 10: e1004196, 2014.
[Journal]
8)  Kroy DC, Ciuffreda D, Cooperrider JH, Tomlinson M, Hauck GD, Aneja J, Berger C, Wolski D, Carrington M, Wherry EJ, Chung RT, Tanabe KK, Elias N, Freeman GJ, de Kruyff RH, Misdraji J, Kim AY, Lauer GM.
Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors.
Gastroenterology. 146: 550-61, 2014.
[Journal]
9)  Hiby SE, Apps R, Chazara O, Farrell LE, Magnus P, Trogstad L, Gjessing HK, Carrington M, Moffett A.
Maternal KIR in Combination with Paternal HLA-C2 Regulate Human Birth Weight.
J. Immunol. 192: 5069-73, 2014.
[Journal]
10)  van Teijlingen NH, Hölzemer A, Körner C, García-Beltrán WF, Schafer JL, Fadda L, Suscovich TJ, Brander C, Carrington M, Evans DT, van Baarle D, Altfeld M.
Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell function.
AIDS. 28: 1399-408, 2014.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 8/4/2014.